StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the stock.
Bio-Path Stock Performance
NASDAQ BPTH opened at $0.78 on Thursday. The company has a 50-day simple moving average of $0.89 and a two-hundred day simple moving average of $1.03. Bio-Path has a 12-month low of $0.59 and a 12-month high of $9.99.
Bio-Path Company Profile
Recommended Stories
- Five stocks we like better than Bio-Path
- How to Invest in the FAANG Stocks
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- How to Profit From Value Investing
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Bio-Path Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Path and related companies with MarketBeat.com's FREE daily email newsletter.